Onward Medical NV (OTCPK:ONWRF)

Q3 2025 ONWARD Medical NV Earnings Call Transcript

Nov 24, 2025 / 01:00 PM GMT

Transcript

Key Points

Positve

Onward Medical NV (ONWRF) exceeded €1.5 million in quarterly revenue, reaching €1.7 million, marking a significant milestone.
The company received CE Mark and US FDA clearance for the RCEX system, expanding its market opportunities in both clinics and homes.
Onward Medical NV raised over €50 million in new equity capital, extending its cash runway into Q1 2027.
The company achieved UL mark certification, enhancing the credibility and safety standards of its RCEX system.
Onward Medical NV continues to strengthen its leadership team with the appointment of experienced executives, enhancing its strategic capabilities.

Negative

The company's cash burn for Q3 was €8 million, driven by ongoing investments in commercialization and R&D.
There is uncertainty regarding reimbursement coverage for home use devices, particularly in the United States.
The uptake of devices within the VA system has been slow due to instability in US government spending and staffing.
Onward Medical NV has not yet pursued a Medicare code for reimbursement, which may limit immediate access for some patients.
The company faces challenges in aligning capital budgeting cycles with clinic customers, which could impact sales timelines.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ONWD.BR - Onward Medical NV
Q3 2025 ONWARD Medical NV Earnings Call
Nov 24, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, good afternoon, everyone, and welcome to our onwards webcast following the publication of our results earlier today.

As usual, before we get started, please take a moment to read our disclaimer. Today's presentation includes forward-looking statements which should be considered with the appropriate level of caution as outlined on this page. The slides and this recording will be available now on the website after the call.

Today's speakers include Dave, our CEO, Sean Shira, our Chief Commercial Officer, and Amy Fraser, our senior finance director.

As usual, we go through a comprehensive update before opening for questions. You may submit your questions verbally or via the Q&A module on the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.